Gene: ZNF550
Official Full Name: zinc finger protein 550provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12169 | ZNF550 Knockout cell line (HeLa) | Human | ZNF550 | 1:3~1:6 | Negative | Online Inquiry |
KO12170 | ZNF550 Knockout cell line (HCT 116) | Human | ZNF550 | 1:2~1:4 | Negative | Online Inquiry |
KO12171 | ZNF550 Knockout cell line (HEK293) | Human | ZNF550 | 1:3~1:6 | Negative | Online Inquiry |
KO12172 | ZNF550 Knockout cell line (A549) | Human | ZNF550 | 1:3~1:4 | Negative | Online Inquiry |
ZNF550 Gene Knockout Cell Lines represent a pioneering advancement in genetic research and therapeutic development. These cell lines are engineered to selectively disrupt the ZNF550 gene, a member of the zinc finger protein family involved in various cellular processes including transcriptional regulation, DNA repair, and differentiation. By creating a knockout model, researchers can investigate the functional consequences of ZNF550 loss, thereby illuminating its role in cellular pathways and disease mechanisms.
The key mechanism of action involves the use of CRISPR/Cas9 technology or other advanced gene-editing techniques to introduce specific mutations that lead to the complete absence of ZNF550 expression. This precise knockout facilitates the study of gene function in a controlled environment, allowing researchers to elucidate the gene’s involvement in signal transduction and gene regulation under various experimental conditions.
The scientific importance of ZNF550 Gene Knockout Cell Lines is underscored by their utility in fundamental research, drug discovery, and the development of novel therapeutic approaches, particularly in oncology and regenerative medicine. The ability to observe phenotype alterations and pathway perturbations in these knockout models provides valuable insights into disease mechanisms and potential treatment targets.
What truly sets these cell lines apart from alternative products is their rigorously validated performance and the comprehensive data provided with each line, ensuring that researchers can replicate experiments reliably. Furthermore, our ZNF550 cell lines are derived from well-characterized sources, ensuring consistency and high-quality results crucial for both academic and clinical applications.
For researchers, clinicians, and companies focused on molecular biology and genetics, investing in high-fidelity gene knockout models such as ZNF550 offers a substantial advantage in advancing scientific knowledge and therapeutic innovation. Our commitment to quality and customer support empowers users to achieve impactful scientific outcomes.
With years of experience in producing top-tier biological products, our company stands as a leader in the field, dedicated to supporting the scientific community with innovative tools and technologies that drive discovery and health advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.